TOP NEWS: AstraZeneca to buy Fusion in deal worth over $2 billion
AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing ‘next-generation’ radioconjugates.
The Cambridge-based pharmaceutical company said the takeover...
Tue, 19/03/2024 - 08:56